Trevi Therapeutics Cash Flow Statement 2017-2024 | TRVI

Fifteen years of historical annual cash flow statements for Trevi Therapeutics (TRVI).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
2023202220212020201920182017
$-29.07$-29.15$-33.94$-32.76$-26.05$-20.55$-12.86
$0.30$0.56$0.65$0.27$0.04$0.08$2.19
$0.90$1.65$2.84$2.43$1.34$2.74$1.98
$1.20$2.21$3.49$2.70$1.38$2.82$4.16
$0$0$0$0$-0.37$-0.14$-0.03
$0$0$0$0$0$0$0
$-1.05$0.01$0.83$0.42$0.78$0.07$0.09
$-2.85$-0.60$0.34$0.74$-0.24$-1.27$-0.05
$-3.85$-1.23$1.51$1.06$1.58$-0.57$0.72
$-31.71$-28.18$-28.95$-29.00$-23.09$-18.29$-7.98
$-0.14$-0.16$0$-0.03$-0.01$-0.16$-0.01
$0$0$0$0$0$0$0
$0$0$0$0$0$0$0
$0$0$0$0$0$0$0
$59.57$-107.21$0$0$0$0$0
$59.57$-107.21$0$0$0$0$0
$0$0$0$0$0$0$0
$59.43$-107.37$0$-0.03$-0.01$-0.16$-0.01
$-9.50$-5.83$0$14.00$0$-4.81$-8.25
$0$0$0$0$0$0$0
$-9.50$-5.83$0$14.00$0$-4.81$-8.25
$0.14$117$13.72$0.05$65.14$0.01$0.06
$0.14$117$13.72$0.05$75.10$10.51$29.98
$0$0$0$0$0$0$0
$1.45$-0.25$7.06$2.67$-1.89$-2.07$-0.01
$-7.91$111$20.78$16.72$73.21$3.63$21.72
$19.81$-24.24$-8.17$-12.31$50.11$-14.82$13.73
$2.25$2.33$2.54$2.42$1.13$0.50$0.21
$0$0$0$0$0$0$0